NW
NVAX icon

NewEdge Wealth’s Novavax NVAX Stock Holding History

NewEdge Wealth’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$947K Sell
100,559
-29,441
-23% -$264K 0.01% 671
2026
Q1 		$1.06M Sell
130,000
-239
-0.2% -$2.17K 0.01% 610
2025
Q4 		$875K Sell
130,239
-39,761
-23% -$300K 0.01% 671
2025
Q3 		$1.31M Sell
170,000
-4,750
-3% -$37K 0.02% 499
2025
Q2 		$1.53M Sell
174,750
-5,255
-3% -$34.8K 0.02% 435
2025
Q1 		$1.15M Buy
180,005
+9,888
+6% +$81.7K 0.02% 446
2024
Q4 		$1.37M Buy
170,117
+70,117
+70% +$676K 0.02% 429
2024
Q3 		$1.26M Hold
100,000
– – 0.02% 430
2024
Q2 		$1.27M Buy
+100,000
New +$1.01M 0.03% 382

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

NewEdge Wealth's NVAX Position: Q2 2026 in Review

NewEdge Wealth reduced its Novavax (NVAX) stake by 23% in Q2 2026, selling an estimated $264K and leaving 100,559 shares worth $947K. The position accounts for 0.01% of the portfolio, ranked #671.

NewEdge Wealth first reported a position in NVAX in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.53M in Q2 2025. 268 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • NewEdge Wealth held 100,559 shares of Novavax worth $947K as of Q2 2026.
  • NewEdge Wealth sold 29,441 Novavax shares in Q2 2026, an estimated $264K.
  • Novavax made up 0.01% of NewEdge Wealth's portfolio in Q2 2026, its #671 holding.
  • NewEdge Wealth first reported a position in Novavax in Q2 2024 and has held it in 9 quarters since.
  • NewEdge Wealth's Novavax position peaked at $1.53M in Q2 2025.
  • 268 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on NewEdge Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.